Abstract: There is provided a process for preparing aluminium chloride comprising leaching aluminium dross residues with H2SO4 so as to obtain a leachate; and hydrochlorinating the leachate so as to obtain aluminium chloride. If desired, aluminium chloride can then be converted into alumina.

Abstract: There is provided a process for preparing aluminium chloride comprising: leaching aluminium dross residues with HCl so as to obtain a mixture comprising a solid and a liquid; and hydrochlorinating the liquid obtained from the mixture, so as to form a precipitate comprising aluminium chloride. Such a sequence can also be used for preparing alumina. In such a case, the process can further comprise the step of converting the so-obtained aluminium chloride into alumina. In the processes previously defined, the solid so-obtained can also be leached with H2SO4, thereby generating a leachate. The leachate can also eventually be hydrochlorinated so as to increase the yield of the desired product obtained i.e. alumina or aluminium chloride.

Abstract: There is provided a system for remote monitoring a plurality of security systems connected to the Internet, the security systems being assigned dynamic IP addresses, each of the security systems comprising a remote monitoring server module, the system comprising a central alarm monitoring service connected to the Internet for periodically communicating with the plurality of security systems and determining a status thereof to generate an alarm signal as a function of the status, the alarm monitoring service storing a current IP address of the plurality of security systems in an IP address database, and a remote monitoring gateway providing authenticated or unauthenticated dynamic domain name service (DDNS) server functionality to connect a given remote monitoring client to a desired one of the security systems, the gateway being connected to the IP address database and to the Internet. There is further provided a method of remote monitoring a security system.

Abstract: Recombinant or transgenic non-human mammals are described having a mutant tryptophan hydroxylase 2 (Tph2) gene resulting in altered synthesis of 5-hydroxytryptophan and serotonin in the brain. In some embodiments the mutant tryptophan hydroxylase 2 gene contains mouse R439H and/or P447R functional mutations, or their corresponding mutations in other species. Congenic non-human mammals having mutant tryptophan hydroxylase 2 genes are also provided. Methods of screening a compound for serotonergic activity or activity in treating a serotonergic neurotransmission dysregulation disorder are provided, which include administering a test compound to a recombinant non-human mammal and then detecting the presence or absence of serotonergic activity, or activity in treating a serotonergic neurotransmission dysregulation disorder, in the mammal. A cell such as a nerve cell (e.g.

Abstract: There is provided a process for reducing formaldehyde content of a gas comprising the step of contacting the gas with an aqueous oxidizing solution comprising at least one cation, a base, and H2O2 so as to oxidize at least a part of the formaldehyde contained in the gas into formic acid. Thus, a gas having a reduced content in formaldehyde as compared to the gas before the process and a solution comprising formic acid, are so-obtained. Such a process can be particularly useful for treating various types of gases containing formaldehyde.

Abstract: The present invention relates to a method for producing whey proteins in nanoparticulated form and to the nanoparticulated whey proteins thus obtained. Specifically, the present invention pertains to the use of these nanoparticulated whey proteins as emulsifiers, fat substitute, micellar casein substitute, whitening, foaming, texturizing and/or filling agents.

Abstract: There is provided a process for reducing formaldehyde content of a gas comprising the step of contacting the gas with an aqueous oxidizing solution comprising at least one cation, a base, and H2O2 so as to oxidize at least a part of the formaldehyde contained in the gas into formic acid. Thus, a gas having a reduced content in formaldehyde as compared to the gas before the process and a solution comprising formic acid, are so-obtained. Such a process can be particularly useful for treating various types of gases containing formaldehyde.

Abstract: A method of treating a subject for a serotonergic neurotransmission dysregulation disorder, comprises administering the subject a serotonin enhancer (e.g., a serotonin reuptake inhibitor) in an amount effective to treat the disorder; and concurrently administering the subject 5-hydroxytryptophan in an amount effective to enhance the activity of the serotonin enahancer, (e.g., serotonin reuptake inhibitor). In preferred embodiments the disorder is depression, anxiety, or substance abuse.

Abstract: Self-foaming, liquid creamers including a first liquid component including an edible acid component, and a second liquid component comprising an edible salt, each liquid being shelf-stable and being operatively associated so that when the first and second liquids are combined carbon dioxide evolves to assist in providing the foam so that, when the liquid creamer is combined with the beverage, a portion of the creamer melts or disperses in less than about 20 seconds in the beverage to impart a creaming flavor and whitening color to the beverage with the remainder of the creamer forming a foam having a density that is less than that of the beverage so as to reside on top of the beverage as a visible foam layer, and methods of making foamed beverages therewith. The amount of foam generated in the beverage is dependent on the overrun of the foaming liquid creamer.

Abstract: A method of screening a subject for a serotonergic neurotransmission dysregulation disorder comprises detecting the presence or absence of an Tph2 mutation in the subject; and then determining that the subject is at increased risk of a serotonergic neurotransmission dysregulation disorder due to the presence or absence of the Tph2 mutation.

Abstract: Fragmentation-based methods and systems, particularly mass spectrometry based methods and systems, for the analysis of sequence variations including haplotypes are provided. Also provided are methods for obtaining a specific allele from a nucleic acid mixture, such as genomic DNA.

Abstract: Provided herein are optimized methods for performing multiplexed detection of a plurality of sequence variations. Also provided are methods for performing multiplexed amplification of target nucleic acid.

Abstract: Use of the E. coli mismatch detection system, MutS, MutL and MutH, in PCR-based, automated, high-throughput genotyping and mutation detection of genomic DNA. Optimal sensitivity and signal-to-noise ratios are dependent upon monovalent cation concentration and MutL concentration. Strategies that can be easily adapted to automation for limiting the analysis to intersample heteroduplexes have been developed.

Abstract: A uridine diphospho-glucuronosyltransferase (UGTB217) is provided. Methods of producing the enzyme and using the enzyme to identify potential compounds which inhibit or alter the activity of the enzyme are described. In addition, methods of using antibodies to localize the protein, or using the gene sequence or portions thereof for probes or using the gene sequence to produce expression-disrupting sense or antisense DNA fragments thereof, or antisense RNA, are provided.

Abstract: The present invention relates to an advantageous and novel method of producing pancreatin which contains low amounts of residual organic solvent, and more particularly to a method which is more environmentally friendly than conventional methods of pancreatin production. More specifically, the present invention relates to a method which utilizes quantities of organic solvents which are about 10 times lower than that of conventional methods. A preferred method of pancreatin preparation, whereby a pancreatic past is autolysed, decontaminated, subjected to an ultrafiltration, dried and then defatted is herein disclosed. The present invention further relates to a pancreatin preparation which contains low amounts of residual solvent. This amount is about 15 to 30 times lower than pancreatin preparation obtained with these conventional methods.